-
FTO–FOXO1 Control of ADSC Osteogenesis
2026-08-30
Wang et al. identify an FTO–FOXO1–RUNX2/PPARG axis through which m6A RNA modification regulates the osteogenic differentiation of adipose-derived stem cells. The study connects FTO-dependent methylation and cytoplasmic FOXO1 mRNA binding with stem-cell migration, proliferation, and bone formation, while also highlighting potential risks of pharmacologically inhibiting FTO during regenerative therapies.
-
Sildenafil Citrate for Proteoform-Aware Vascular Research
2026-08-29
Sildenafil Citrate combines nanomolar PDE5 inhibition with practical utility in cGMP, vascular smooth muscle, PASMC, and native membrane-proteomics workflows. This guide translates its mechanism into assay-ready workflows while highlighting proteoform-dependent off-target binding and troubleshooting strategies.
-
circHIF1A Axis Drives LUAD Progression and M2 Polarization
2026-08-28
A 2026 study identifies circHIF1A as an oncogenic circular RNA that connects lung adenocarcinoma cell-intrinsic aggressiveness with macrophage M2 polarization through the miR-486-5p/GRHL2 axis. Its combined patient, cell, and xenograft design supports a mechanistic model in which circRNA-mediated RNA regulation contributes to both tumor progression and immune-microenvironment remodeling.
-
Dual-Action Inhibition of p38α Dephosphorylation
2026-08-28
The reference preprint shows that some p38α kinase inhibitors do more than block catalytic activity: they also expose the activation-loop phosphothreonine to the phosphatase WIP1, accelerating kinase dephosphorylation. Biochemical kinetics and X-ray structures support a conformation-directed strategy that may improve the specificity and durability of p38 pathway modulation, while remaining distinct from direct phosphatase recruitment.
-
Tigecycline for MDR Research Workflows
2026-08-27
Tigecycline is a glycylcycline antibiotic for building reproducible susceptibility, resistance, and infection-model workflows involving multidrug-resistant organisms. This guide connects concentration-controlled phenotyping with plasmid and carbapenemase surveillance, while emphasizing stock handling, bacteriostatic readouts, and translational limits.
-
Actinomycin D: Workflow, Applications, and Troubleshooting
2026-08-27
Actinomycin D (ActD) provides a practical way to impose controlled transcriptional stress in cell-based assays, from mRNA half-life measurements to apoptosis and cancer research models. This workflow-focused guide explains dose selection, handling, stem-cell assay integration, and troubleshooting for more interpretable results.
-
Neuroligin 1 Proteolysis in Social Memory Maintenance
2026-08-26
The reference study identifies activity-dependent proteolysis of Neuroligin 1 (NLG1) in the ventral hippocampus as a molecular process that sustains social memory after social interaction. Its experiments connect NLG1-CTD production to cofilin signaling, dendritic spine remodeling, and behavioral rescue, offering a mechanistic framework for memory maintenance rather than memory formation alone.
-
Cucurbitacin I Workflows for STAT3 Research
2026-08-26
Cucurbitacin I, also known as JSI-124, provides a practical way to interrogate JAK2/STAT3-dependent cancer phenotypes across signaling, apoptosis, migration, and therapy-response assays. This workflow emphasizes matched controls, orthogonal readouts, and careful interpretation of context-dependent effects such as protective autophagy.
-
Prochlorperazine in Melanoma: COLO829 and C32
2026-08-25
The reference study examined prochlorperazine and perphenazine across melanotic COLO829 and amelanotic C32 melanoma cells, combining viability, motility, and melanocytic protein endpoints. Its main contribution is a phenotype-aware view of phenothiazine activity, while also showing why MITF and tyrosinase changes require careful interpretation before translation to cancer research.
-
Cy5 TSA Fluorescence System Kit: Mechanism & Use
2026-08-25
The Cy5 TSA Fluorescence System Kit uses horseradish peroxidase catalyzed tyramide deposition to increase fluorescent detection of scarce targets in ICC, IHC, and FISH. Its product-stated Cy5 readout uses 648 nm excitation and 667 nm emission, while the reported approximately 100-fold sensitivity gain remains assay-dependent.
-
Prednisone: Reliable Cell Assay Workflows
2026-08-24
This scenario-driven guide shows how Prednisone, SKU B2148, can help researchers control solvent effects, interpret lymphocyte viability and apoptosis data, and build reproducible corticosteroid assays. It combines mechanism-based experimental design with practical handling, storage, and vendor-selection guidance.
-
Sulfo-Cy3 NHS Ester for Vascular Assays
2026-08-24
Sulfo-Cy3 NHS Ester combines water compatibility with amine-selective labeling, making it useful for tracking vascular proteins, uptake pathways, and endothelial-cell remodeling without relying on organic cosolvents. This practical guide connects the dye to the AIBP-LRP2–HDL–CXCR4 biology of collateral circulation and provides starting conditions for reproducible conjugation, imaging, and troubleshooting.
-
Amorolfine Hydrochloride and Fungal Cell Integrity
2026-08-23
Amorolfine Hydrochloride is an antifungal reagent for studying membrane-synthesis phenotypes through a ploidy-aware assay framework. This article connects product handling, fungal cell membrane disruption, and the latest yeast evidence to improve mechanistic and antifungal resistance studies.
-
IGF2BP3–RCC2 Axis in Acute Myeloid Leukemia
2026-08-22
The reference study identifies the m6A reader IGF2BP3 as an AML-associated survival factor that promotes leukemic progression by stabilizing RCC2 mRNA. Its combination of patient-sample analysis, cellular perturbation, RNA-binding experiments, and in vivo validation connects an epitranscriptomic regulator to a defined post-transcriptional mechanism with implications for cancer research.
-
Actinomycin D Workflows for RNA Stability Research
2026-08-22
Actinomycin D enables controlled transcription shutdown for mRNA decay, apoptosis induction, and transcriptional stress studies. This workflow translates the FTO–FOXO1 findings in adipose-derived stem cells into practical ActD assay designs while emphasizing dose control, RNA normalization, and cytotoxicity-aware interpretation.